Showing 1 - 10 of 1,641
toolkit introduces medical liability as an intrinsic component of tort law, which itself must be understood as a part of … of medical liability, and the nature of the alleged “crisis,” the toolkit indicates how reform has been attempted at the … clause drafting. The toolkit also includes an up-to-date list of medical liability reforms in the fifty states, the only such …
Persistent link: https://www.econbiz.de/10014173652
availability of health-related products such as pharmaceuticals, vaccines, and medical equipment. The case for liberalizing trade …
Persistent link: https://www.econbiz.de/10011591118
As managed care responds to the rising tide of consumerism in medicine, it is necessary to reexamine the functions that health plans have performed. Chief among the activities that demand resources but return minimal value is the process of physician credentialing. As consumers are asked to...
Persistent link: https://www.econbiz.de/10014108039
This paper explains how the current architecture of the pharmaceutical markets has created a misalignment of financial incentives and public health that is a central cause of harmful practices. It explores three possible solutions to address that misalignment: taxes, increased financial...
Persistent link: https://www.econbiz.de/10014156280
We consider how patent rights and price regulation affect whether new drugs are marketed in a country, and how quickly. The analysis covers a large sample of 68 countries at all income levels and includes all drug launches over the period 1982-2002. It uses newly compiled information on legal...
Persistent link: https://www.econbiz.de/10014026156
This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems coinsurance and indemnity insurance are compared with respect to changes in copayments and public health...
Persistent link: https://www.econbiz.de/10013071665
The portfolio approach of financing drug development has been proposed as a financial innovation to improve the risk/return tradeoff of investment in drug development projects through the use of diversification and securitization. By investing in a sizable and well-diversified portfolio of novel...
Persistent link: https://www.econbiz.de/10014343742
In a sign of their increasing frustration with global efforts to ensure that all people everywhere will have access to COVID-19 vaccines, several developing countries have asked other members of the World Trade Organization (WTO) to join them in a sweeping waiver of the intellectual property...
Persistent link: https://www.econbiz.de/10013248992
Persistent link: https://www.econbiz.de/10003484249
they conceptualise and consecutively propose to solve the problem of providing life-saving pharmaceuticals to the poor in …
Persistent link: https://www.econbiz.de/10011757929